Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 36NET 2Endocrine 2Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Classical hematology 1Breast 1

Conditions

Multiple Myeloma 463Neoplasms, Plasma Cell 81Lymphoma 75Leukemia 51Lymphoma, Non-Hodgkin 49Leukemia, Lymphocytic, Chronic, B-Cell 45Myelodysplastic Syndromes 43Immunoglobulin Light-chain Amyloidosis 42Leukemia, Myeloid, Acute 39Hodgkin Disease 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Neoplasms 32Hematologic Neoplasms 31Breast Neoplasms 31Myeloproliferative Disorders 29Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 29Monoclonal Gammopathy of Undetermined Significance 28Smoldering Multiple Myeloma 25Lymphoma, Mantle-Cell 25Lymphoma, B-Cell, Marginal Zone 24Recurrence 23Burkitt Lymphoma 21Amyloidosis 21Prostatic Neoplasms 20Lymphoma, T-Cell, Cutaneous 20Lymphoma, Large-Cell, Immunoblastic 19Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 19Waldenstrom Macroglobulinemia 18Sezary Syndrome 18

Interventions

Tinzaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Digestive System Neoplasms × Plasma cell × Clear all
NCT03099031 2019-12-16

PREDICARE

LEO Pharma

Completed
420 enrolled
BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Digestive System Neoplasms, Intestinal Neoplasms, Leukemia, Lung Neoplasms, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Prostatic Neoplasms, Thromboembolism, Urogenital Neoplasms, Vascular Diseases, Colorectal Neoplasms, Hemostatic Disorders, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡